RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
144 hedge funds and large institutions have $2.47B invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 146 → 144 (-2)
88% less call options, than puts
Call options by funds: $3.53M | Put options by funds: $30.7M
Holders
144
Holding in Top 10
11
Calls
$3.53M
Puts
$30.7M
Top Buyers
| 1 | +$89.4M | |
| 2 | +$53.7M | |
| 3 | +$43.5M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$37.6M |
| 5 |
TAL
TIG Advisors LLC
New York
|
+$36.2M |
Top Sellers
| 1 | -$71.3M | |
| 2 | -$46.1M | |
| 3 | -$35.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$34.9M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$33.3M |